The performance of treating the cardiac diseases is dependent on the kind of drug being selected. There exist numerous decisive support systems which work according to certain characteristics and factors like drug availability, and popularity. Still, they struggle to achieve expected performance in supporting the medical practitioner. To handle this issue, a multi feature drug curing rate based drug compound selection and recommendation system (MDCRSR) is presented. The method utilizes medical histories and data set of various medical organization around the disease considered. Using the traces, the method identifies the drug compounds and features to perform preprocessing which eliminates the noisy data points. Further, the features of the traces are extracted to perform training with genetic algorithm. At the test phase, the method estimates the fitness measure for different drug combination and compounds by measuring their Drug Curing Rate (DCR). The method performs cross over and mutation to produce various populations of drug compounds. According to the curing rate, the drug compound pattern or population is selected and ranked. The ranked results are populated to the medical practitioner. The method improves the performance of recommendation system as well as drug compound selection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.